IGC Applauds Signing of Bipartisan Medical Marijuana and Cannabidiol Research Expansion Act

December 7, 2022

https://www.globenewswire.com/news-release/2022/12/07/2569318/0/en/IGC-Applauds-Signing-of-Bipartisan-Medical-Marijuana-and-Cannabidiol-Research-Expansion-Act.html

POTOMAC, Md., Dec. 07, 2022 (GLOBE NEWSWIRE) — via InvestorWire — India Globalization Capital, Inc (NYSE American: IGC) (“IGC” or the “Company”), applauds the signing of the Medical Marijuana and Cannabidiol Research Expansion Act (“the Act”), which was signed into law by President Biden on Friday Dec. 2, 2022. The law provides legislation establishing a new registration process for conducting research on marijuana and for manufacturing marijuana products for research purposes and drug development.

Read more at globenewswire.com

Related news for (IGC)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.